Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta …
P Shamsrizi, BP Gladstone, E Carrara, D Luise… - BMJ open, 2020 - bmjopen.bmj.com
Objective To assess the variation of effect estimates in the analysis of mortality and length of
stay (LOS) in patients with infections caused by extended-spectrum beta-lactamase (ESBL) …
stay (LOS) in patients with infections caused by extended-spectrum beta-lactamase (ESBL) …
ESBL-producing Enterobacteriaceae in Africa – a non-systematic literature review of research published 2008–2012
V Storberg - Infection ecology & epidemiology, 2014 - Taylor & Francis
Introduction Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBL) has
been found all over the world, and risk factors for acquiring these bacteria involve hospital …
been found all over the world, and risk factors for acquiring these bacteria involve hospital …
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines
M Mikulska, D Averbuch, F Tissot, C Cordonnier… - Journal of Infection, 2018 - Elsevier
Objectives Fluoroquinolone (FQ) prophylaxis was recommended in 2005 by European
Conference on Infections in Leukemia (ECIL) for patients with prolonged neutropenia. In …
Conference on Infections in Leukemia (ECIL) for patients with prolonged neutropenia. In …
Epidemiology and characteristics of urinary tract infections in children and adolescents
RH Hanna-Wakim, ST Ghanem… - Frontiers in cellular …, 2015 - frontiersin.org
Background: Urinary tract infections (UTIs) are among the most common infections in the
pediatric population. Over the last two decades, antibiotic resistance is increasing …
pediatric population. Over the last two decades, antibiotic resistance is increasing …
Community-onset extended-spectrum β-lactamase (ESBL) producing Escherichia coli: importance of international travel
KB Laupland, DL Church, J Vidakovich, M Mucenski… - Journal of Infection, 2008 - Elsevier
OBJECTIVES: Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli have
emerged as significant causes of community-onset disease. We sought to identify risk factors …
emerged as significant causes of community-onset disease. We sought to identify risk factors …
High prevalence of extended-spectrum ß-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso
AS Ouedraogo, M Sanou, A Kissou, S Sanou… - BMC infectious …, 2016 - Springer
Background Nothing is known about the epidemiology and resistance mechanisms of
extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso …
extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso …
Microbiological profile and antimicrobial resistance among diabetic foot infections in Lebanon
L Jouhar, RF Jaafar, R Nasreddine… - International Wound …, 2020 - Wiley Online Library
Abstract Diabetic Foot Infection (DFI) is a challenging complication of diabetes mellitus with
a high burden in the Middle East where there is a marked increase in diabetes prevalence …
a high burden in the Middle East where there is a marked increase in diabetes prevalence …
Incidence pattern, antibiotic susceptibility pattern and associated risk factors of bacterial Uropathogens among general population of Pakistan
Purpose Urinary tract infections (UTIs) are of the most common bacterial infections in
Pakistan. Rapid increase in antibiotic resistance has resulted in a limited number of …
Pakistan. Rapid increase in antibiotic resistance has resulted in a limited number of …
[HTML][HTML] Evolución de la resistencia antimicrobiana de bacilos Gram negativos en unidades de cuidados intensivos en Colombia
Introducción. La evolución de la resistencia bacteriana constituye una amenaza para la
salud pública mundial. Los sistemas de vigilancia epidemiológica han integrado técnicas de …
salud pública mundial. Los sistemas de vigilancia epidemiológica han integrado técnicas de …
[HTML][HTML] Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea
SY Cho, HJ Lee, DG Lee - The Korean journal of internal medicine, 2018 - ncbi.nlm.nih.gov
Hematopoietic stem cell transplantation (HSCT) is a treatment for hematologic malignancies,
immune deficiencies, or genetic diseases, ect. Recently, the number of HSCTs performed in …
immune deficiencies, or genetic diseases, ect. Recently, the number of HSCTs performed in …